Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction

Hypertension

Volumn 32, Issue 3, 1998, Pages 521-526

  Hibi, Kiyoshi ^a   Ishigami, Tomoaki ^a   Tamura, Kouichi ^a   Mizushima, Shunsaku ^a   Nyui, Nobuo ^a   Fujita, Takayuki ^a   Ochiai, Hisao ^a   Kosuge, Masami ^a   Watanabe, Yasujirou ^a   Yoshii, Yuzuru ^b   Kihara, Minoru ^a   Kimura, Kazuo ^a   Ishii, Masao ^a   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Saiseikai Yokohama City Nanbu Hospital   (Japan)

Author keywords

Angiography; Atherosclerosis; Endothelium derived relaxing factor; Genes; Myocardial infarction

Indexed keywords

NITRIC OXIDE SYNTHASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY SPASM; DNA POLYMORPHISM; ENDOTHELIUM; FEMALE; GENE MUTATION; GENETIC PREDISPOSITION; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POINT MUTATION; PRIORITY JOURNAL;

EID: 0031704975     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.3.521     Document Type: Article

References (27)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. New Engl J Med 1993;329:2002-2012.
2. Moncada S. The L-arginine-nitric oxide pathway. Acta Physiol Scand. 1992;145:201-227.
3. Shibuki K, Okada D. Endogenous nitric oxide release required for long-term synaptic depression in the cerebellum. Nature. 1991;349: 326-328.
4. Kihara M, Umemura S, Kadota T, Yabana M, Tamura K, Nyui N, Ogawa N, Murakami K, Fukamizu A, Ishii M. The neuronal isoform of constitutive nitric oxide synthase is up-regulated in the macula densa of angiotensinogen gene-knockout mice. Lab Invest. 1997;76:285-294.
5. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
6. Quyyumi AA, Dakak N, Andrews NP, Husain S, Arora S, Gilligan DM, Panza JA, Cannon RO III. Nitric oxide activity in the human coronary circulation. J Clin Invest. 1995;95:1747-1755.
7. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation. 1996;94:266-272.
8. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8- bromocyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1774-1777.
9. Furlong B, Henderson AH, Lewis MJ, Smith JA. Endothelium-derived relaxing factor inhibits in vitro platelet aggregation. Br J Pharmacol. 1987;90:687-692.
10. Yao S-K, Ober JC, Krishnaswami A, Ferguson JJ, Anderson V, Golino P, Buja LM, Willerson JT. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation. 1992;86:1302-1309.
11. Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987; 2:1057-1058.
12. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:4651-4655.
13. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat Med. 1996;2:41-45.
14. Yasue H, Yoshimura M, Sugiyama S, Sumida H, Okumura K, Ogawa H, Kugiyama K, Ogawa Y, Nakao K. Association of a point mutation of the endothelial cell nitric oxide synthase (eNOS) gene with coronary spasm. Circulation. 1995;92:I-363. Abstract.
15. World Health Organization. Report of the Joint International Society, and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature: nomenclature and criteria for diagnosis of ischemic heart disease. Circulation. 1979;59:607-609.
16. Wang XL, Tam C, McCredie RM, Wilcken DEL. Determinants of severity of coronary artery disease in Australian men and women. Circulation. 1994;89:1974-1981.
17. World Health Organization Expert Committee on Arterial Hypertension. Arterial Hypertension. WHO Technical Report Series, No. 628. Geneva, Switzerland: WHO; 1978:7-11.
18. Hibi K, Ishigami T, Kimura K, Nakao M, Iwamoto T, Tamura K, Nemoto T, Shimizu T, Mochida Y, Ochiai H, Umemura S, Ishii M. Angiotensin-converting enzyme gene polymorphism adds risk for the severity of coronary atherosclerosis in smokers. Hypertension. 1997;30:574-579.
19. Armitage P, Berry G. Statistical Methods in Medical Research. 3rd ed. Oxford, UK: Blackwell Science: 1994:132-144.
20. Bonnardeaux A, Nadaud S, Charru A, Jeunemaitre X, Corvol P, Soubrier F. Lack of evidence for linkage of the endothelial cell nitric oxide synthase gene to essential hypertension. Circulation. 1995;91:96-102.
21. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, Nyuui N, Kimura K, Miyazaki N, Ishii M. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 1995;91:951-954.
22. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P, Arveiler D, Luc G, Bard J-M, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F, Soubrier F. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641-644.
23. Wang XL, McCredie RM, Wilcken DEL. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol. 1995;15:1030-1034.
24. Cayatte AJ, Palacino JJ, Horten K, Cohen RA. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 1994;14: 753-759.
25. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
26. Yamagishi M, Miyatake K, Tamai J, Nakatani S, Koyama J, Nissen SE. Intravascular ultrasound detection of atherosclerosis at the site of focal vasospasm in angiographically normal or minimally narrowed coronary segments. J Am Coll Cardiol. 1994;23:352-357.
27. Quyyumi AA, Dakak N, Mulcahy D, Andrews NP, Husain S, Panza JA, Cannon R III. Nitric oxide activity in the atherosclerotic human coronary circulation. J Am Coll Cardiol. 1997;29:308-317.